$214.30
3.141.49%
À la fermeture: -
$214.00
-0.30-0.14%
Après les heures de négociation: 4:04 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Allstate Corp a un objectif de cours consensuel de $220.2 basé sur les évaluations de 21 analystes. Le plus élevé est $285, publié par B of A Securities le novembre 20, 2024. Le plus bas est $22, publié par Piper Sandler le août 14, 2025. Les 3 évaluations d’analystes les plus récentes ont été publiées par Keefe, Bruyette & Woods, UBS et Wells Fargo le novembre 11, 2025, novembre 10, 2025 et novembre 7, 2025, respectivement. Avec un objectif de cours moyen de $240.33 entre Keefe, Bruyette & Woods, UBS et Wells Fargo, il existe une variation implicite de 12.31% upside pour Allstate Corp selon ces dernières évaluations d’analystes.
Sociétés d'analyse émettant des recommandations1
Keefe, Bruyette & Woods
UBS
Wells Fargo
BMO Capital
JP Morgan
1calculé à partir des notes des analystes
Notes d'analystes pour Allstate
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/11/2025 | 16.82% | Keefe, Bruyette & Woods | $246 → $250 | Maintains | Outperform | |||
11/10/2025 | 19.16% | UBS | $250 → $255 | Maintains | Buy | |||
11/07/2025 | 0.93% | Wells Fargo | $202 → $216 | Maintains | Equal-Weight | |||
11/07/2025 | 14.02% | BMO Capital | $235 → $244 | Maintains | Outperform | |||
11/06/2025 | 21.5% | JP Morgan | $254 → $260 | Maintains | Overweight | |||
10/24/2025 | -7.94% | Wells Fargo | $200 → $197 | Maintains | Equal-Weight | |||
10/09/2025 | 18.69% | JP Morgan | $235 → $254 | Maintains | Overweight | |||
10/08/2025 | 16.82% | UBS | $235 → $250 | Maintains | Buy | |||
09/16/2025 | 9.81% | Wolfe Research | → $235 | Initiates | → Outperform | |||
08/20/2025 | 9.81% | BMO Capital | $230 → $235 | Maintains | Outperform | |||
08/14/2025 | -89.72% | Piper Sandler | $20 → $22 | Maintains | Overweight | |||
08/11/2025 | 19.16% | Jefferies | $254 → $255 | Maintains | Buy | |||
08/06/2025 | 14.95% | Keefe, Bruyette & Woods | $237 → $246 | Maintains | Outperform | |||
08/05/2025 | -5.61% | Wells Fargo | $197 → $202 | Maintains | Equal-Weight | |||
08/04/2025 | 21.5% | Raymond James | $250 → $260 | Reiterates | Strong Buy → Strong Buy | |||
08/01/2025 | 14.49% | Morgan Stanley | $235 → $245 | Maintains | Overweight | |||
07/31/2025 | -7.48% | Barclays | $188 → $198 | Maintains | Underweight | |||
07/09/2025 | 10.75% | Keefe, Bruyette & Woods | $235 → $237 | Maintains | Outperform | |||
07/09/2025 | 9.81% | UBS | $230 → $235 | Maintains | Buy | |||
07/07/2025 | -12.15% | Barclays | $172 → $188 | Maintains | Underweight | |||
06/06/2025 | — | William Blair | — | Initiates | → Sector Outperform | |||
05/11/2025 | 7.48% | BMO Capital | $222 → $230 | Maintains | Outperform | |||
05/07/2025 | 9.81% | Keefe, Bruyette & Woods | $228 → $235 | Maintains | Outperform | |||
05/06/2025 | 9.81% | Morgan Stanley | $225 → $235 | Maintains | Overweight | |||
05/06/2025 | -7.94% | Wells Fargo | $200 → $197 | Maintains | Equal-Weight | |||
05/05/2025 | 16.82% | Raymond James | $240 → $250 | Reiterates | Strong Buy → Strong Buy | |||
05/01/2025 | 7.48% | Evercore ISI Group | $227 → $230 | Maintains | Outperform | |||
04/11/2025 | -19.63% | Barclays | $183 → $172 | Maintains | Underweight | |||
04/09/2025 | 6.54% | Keefe, Bruyette & Woods | $240 → $228 | Maintains | Outperform | |||
04/08/2025 | 3.74% | JP Morgan | $217 → $222 | Maintains | Overweight | |||
02/11/2025 | 12.15% | Keefe, Bruyette & Woods | $235 → $240 | Maintains | Outperform | |||
01/20/2025 | 9.81% | Keefe, Bruyette & Woods | $243 → $235 | Maintains | Outperform | |||
01/14/2025 | -12.62% | Wells Fargo | $186 → $187 | Maintains | Equal-Weight | |||
01/10/2025 | 13.55% | Keefe, Bruyette & Woods | $235 → $243 | Maintains | Outperform | |||
01/06/2025 | -14.49% | Barclays | $187 → $183 | Maintains | Underweight | |||
11/26/2024 | 14.02% | Piper Sandler | $206 → $244 | Maintains | Overweight | |||
11/20/2024 | 33.18% | B of A Securities | $263 → $285 | Maintains | Buy | |||
11/15/2024 | 7.48% | Goldman Sachs | $209 → $230 | Maintains | Buy | |||
11/08/2024 | 24.77% | Jefferies | $231 → $267 | Maintains | Buy | |||
11/07/2024 | 6.54% | Morgan Stanley | $220 → $228 | Maintains | Overweight | |||
11/06/2024 | 5.14% | Keefe, Bruyette & Woods | $222 → $225 | Maintains | Outperform | |||
11/05/2024 | -13.08% | Wells Fargo | $175 → $186 | Maintains | Equal-Weight | |||
11/04/2024 | 5.14% | UBS | $216 → $225 | Maintains | Buy | |||
10/31/2024 | -12.62% | Barclays | $175 → $187 | Maintains | Underweight | |||
10/21/2024 | 0.47% | Morgan Stanley | $202 → $215 | Maintains | Overweight | |||
10/18/2024 | -3.27% | Goldman Sachs | $210 → $207 | Maintains | Buy | |||
10/18/2024 | 8.88% | B of A Securities | $216 → $233 | Maintains | Buy | |||
10/18/2024 | — | BMO Capital | $205 → $214 | Maintains | Outperform | |||
10/15/2024 | 0.93% | UBS | $215 → $216 | Maintains | Buy | |||
10/10/2024 | -3.27% | JP Morgan | $205 → $207 | Maintains | Overweight | |||
10/10/2024 | 0.93% | B of A Securities | $226 → $216 | Maintains | Buy | |||
10/09/2024 | 7.94% | Jefferies | $217 → $231 | Maintains | Buy | |||
10/09/2024 | -8.88% | Evercore ISI Group | $191 → $195 | Maintains | In-Line | |||
10/04/2024 | 2.8% | Raymond James | $205 → $220 | Maintains | Strong Buy | |||
09/04/2024 | -18.22% | Barclays | → $175 | Initiates | → Underweight | |||
09/03/2024 | 4.67% | TD Cowen | $193 → $224 | Maintains | Buy | |||
08/16/2024 | -8.41% | Piper Sandler | $188 → $196 | Maintains | Overweight | |||
08/16/2024 | -2.8% | Keefe, Bruyette & Woods | $208 → $208 | Maintains | Outperform | |||
08/16/2024 | -18.22% | Wells Fargo | $177 → $175 | Maintains | Equal-Weight | |||
08/15/2024 | -4.67% | Goldman Sachs | $199 → $204 | Maintains | Buy | |||
08/14/2024 | -6.54% | Roth MKM | $200 → $200 | Reiterates | Buy → Buy | |||
08/12/2024 | -2.8% | Keefe, Bruyette & Woods | $199 → $208 | Maintains | Outperform | |||
08/12/2024 | -17.29% | Wells Fargo | → $177 | Upgrade | Underweight → Equal-Weight | |||
08/05/2024 | -4.21% | BMO Capital | $191 → $205 | Maintains | Outperform | |||
08/01/2024 | -5.61% | Morgan Stanley | $200 → $202 | Maintains | Overweight | |||
08/01/2024 | 5.61% | B of A Securities | $213 → $226 | Maintains | Buy | |||
07/19/2024 | -7.01% | Goldman Sachs | $197 → $199 | Maintains | Buy | |||
07/18/2024 | -10.75% | BMO Capital | $190 → $191 | Upgrade | Market Perform → Outperform | |||
07/11/2024 | -6.54% | JP Morgan | $193 → $200 | Maintains | Overweight | |||
07/10/2024 | -6.54% | Morgan Stanley | $205 → $200 | Maintains | Overweight | |||
07/05/2024 | -9.35% | Keefe, Bruyette & Woods | $194 → $194 | Maintains | Outperform | |||
06/21/2024 | -9.35% | Keefe, Bruyette & Woods | $194 → $194 | Maintains | Outperform | |||
05/10/2024 | -28.5% | Wells Fargo | $146 → $153 | Maintains | Underweight | |||
05/02/2024 | -9.81% | JP Morgan | $185 → $193 | Maintains | Overweight | |||
04/15/2024 | -11.21% | Morgan Stanley | $187 → $190 | Maintains | Overweight | |||
04/11/2024 | -31.78% | Wells Fargo | $145 → $146 | Maintains | Underweight | |||
04/11/2024 | -19.16% | Evercore ISI Group | $166 → $173 | Maintains | In-Line | |||
04/10/2024 | -11.68% | Keefe, Bruyette & Woods | $181 → $189 | Maintains | Outperform | |||
04/08/2024 | -13.55% | JP Morgan | $172 → $185 | Maintains | Overweight | |||
04/08/2024 | -6.54% | Roth MKM | $175 → $200 | Reiterates | Buy → Buy | |||
04/01/2024 | -12.15% | Piper Sandler | $172 → $188 | Maintains | Overweight | |||
03/28/2024 | -11.21% | HSBC | → $190 | Upgrade | Hold → Buy | |||
03/25/2024 | -8.88% | Goldman Sachs | $164 → $195 | Maintains | Buy | |||
02/14/2024 | -15.42% | Keefe, Bruyette & Woods | $171 → $181 | Maintains | Outperform | |||
02/12/2024 | -13.55% | UBS | $171 → $185 | Maintains | Buy | |||
02/09/2024 | -32.24% | Wells Fargo | $112 → $145 | Maintains | Underweight | |||
02/08/2024 | -19.63% | JP Morgan | $164 → $172 | Maintains | Overweight | |||
01/22/2024 | -15.89% | Raymond James | $155 → $180 | Maintains | Strong Buy | |||
01/19/2024 | -26.17% | BMO Capital | $140 → $158 | Maintains | Market Perform | |||
01/10/2024 | -20.09% | UBS | $160 → $171 | Maintains | Buy | |||
01/10/2024 | -9.81% | TD Cowen | → $193 | Initiates | → Outperform | |||
01/09/2024 | -15.89% | Jefferies | $130 → $180 | Upgrade | Hold → Buy | |||
01/09/2024 | -23.36% | Goldman Sachs | $141 → $164 | Maintains | Buy | |||
01/04/2024 | -20.09% | Morgan Stanley | $117 → $171 | Upgrade | Equal-Weight → Overweight | |||
12/28/2023 | -32.24% | HSBC | → $145 | Initiates | → Hold | |||
12/15/2023 | -34.58% | BMO Capital | $125 → $140 | Maintains | Market Perform | |||
12/07/2023 | -25.23% | UBS | $152 → $160 | Maintains | Buy | |||
11/07/2023 | -34.11% | Goldman Sachs | $128 → $141 | Maintains | Buy | |||
11/06/2023 | -27.57% | Raymond James | $145 → $155 | Maintains | Strong Buy | |||
11/03/2023 | -35.51% | Piper Sandler | $137 → $138 | Maintains | Overweight |
FAQ
Quel est le cours indicatif de l'action Allstate (ALL) ?
Le dernier objectif de prix pour Allstate (NYSE:ALL) a été rapporté par Keefe, Bruyette & Woods le novembre 11, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $250.00 s'attendant à ce que ALL se rise dans les 12 prochains mois (un possible changement de 16.82% upside). 37 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Allstate (ALL) ?
La dernière note d'analyste pour Allstate (NYSE:ALL) a été fournie par Keefe, Bruyette & Woods, et Allstate maintenu leur note outperform.
Quand a eu lieu la dernière mise à niveau pour Allstate (ALL) ?
La dernière amélioration pour Allstate Corp a eu lieu le août 12, 2024 lorsque Wells Fargo a augmenté leur objectif de prix à $177. Wells Fargo avait précédemment an underweight pour Allstate Corp.
Quand a eu lieu la dernière dégradation pour Allstate (ALL) ?
Il n'y a pas de dernière réduction pour Allstate.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Allstate (ALL) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Allstate, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Allstate a été déposée le novembre 11, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers novembre 11, 2026.
La note d'analyste pour Allstate (ALL) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Allstate (ALL) était un maintenu avec un objectif de prix de $246.00 à $250.00. Le prix actuel de Allstate (ALL) est de $214.00, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.